from Reuters: Top News http://ift.tt/2G6zEqj
//
Sanofi to buy U.S. haemophilia group Bioverativ for $11.6 billion
January 22, 2018 / / in news, Reuters: Top News / with No comments /
PARIS (Reuters) - French healthcare group Sanofi has agreed to buy U.S. haemophilia specialist Bioverativ for $11.6 billion, in a deal which it said would boost earnings and strengthen its presence in treatments for rare diseases.
from Reuters: Top News http://ift.tt/2G6zEqj
//
from Reuters: Top News http://ift.tt/2G6zEqj
//
Related Posts:
Escaped Psychiatric Patient, Once Described as a Classic Serial Killer, Could Be in California- Jeff Sessions admits there is not enough evidence for the FBI to investigate Hillary Clinton
- Quick-thinking school staff saved kids at California school - ABC News
- Exclusive: Apple to help India develop anti-spam app after face-off with regulator
- Two U.S. Senate Republicans critical of party's tax plan
0 comments:
Post a Comment